These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15700904

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The association between pharmacy closures and prescription drug use: a retrospective analysis of Medicaid prescription claims in Iowa.
    Xiao H, Sorofman B, Manasse HR.
    Am J Manag Care; 2000 Mar; 6(3):366-72. PubMed ID: 10977436
    [Abstract] [Full Text] [Related]

  • 5. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.
    Bagchi AD, Esposito D, Kim M, Verdier J, Bencio D.
    Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The cost effect of newer medication adoption in an older Medicaid cohort.
    Shireman TI, Rigler SK, Jachna CM, Griebling TL, Eng ML.
    J Am Geriatr Soc; 2005 Aug; 53(8):1366-73. PubMed ID: 16078963
    [Abstract] [Full Text] [Related]

  • 10. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS, Miller GE.
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [Abstract] [Full Text] [Related]

  • 11. Principal components analysis of drug expenditure and utilisation trends for major therapeutic classes in US Medicaid programmes.
    Guo JJ, Jing Y, Nguyen K, Fan H, Li X, Kelton CM.
    J Med Econ; 2008 May; 11(4):671-94. PubMed ID: 19450075
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C, Pugmire B, Salness T, Culbertson V, Force R, Cady P, Steiner J.
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [Abstract] [Full Text] [Related]

  • 14. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D, Hoadley J, Kaye N, Crowley J, Hostetter M.
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [Abstract] [Full Text] [Related]

  • 15. Physician satisfaction with formulary policies: is it access to formulary or nonformulary drugs that matters most?
    Glassman PA, Good CB, Kelley ME, Bradley M, Valentino M.
    Am J Manag Care; 2004 Mar; 10(3):209-16. PubMed ID: 15032258
    [Abstract] [Full Text] [Related]

  • 16. Effects of a Medicaid prior authorization policy for pregabalin.
    Margolis JM, Johnston SS, Chu BC, Onukwugha E, Hvidsten K, Alvir J, Rossi JG, Mullins CD.
    Am J Manag Care; 2009 Oct 01; 15(10):e95-102. PubMed ID: 19817512
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R, Smith MJ.
    Clin Ther; 2007 Nov 01; 29(11):2456-67. PubMed ID: 18158087
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.